yes will definitely be longer term. In the medium term though the US sales need to maintain traction and be stable. If one or two quarters show slowing growth the stock will get punished.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025